1. Repository of OAI
Ελληνικά   English  

Browsing by Author Fountzilas, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 52 to 71 of 168 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant settingBriasoulis, E.; Andreopoulou, E.; Tolis, C. F.; Bairaktari, E.; Katsaraki, A.; Dimopoulos, M. A.; Fountzilas, G.; Seferiadis, C.; Pavlidis, N.24-Nov-2015-
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology GroupNicolaides, C.; Dimopoulos, M. A.; Samantas, E.; Bafaloukos, D.; Kalofonos, C.; Fountzilas, G.; Razi, E.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II studySkarlos, D. V.; Kalofonos, H. P.; Fountzilas, G.; Dimopoulos, M. A.; Pavlidis, N.; Razis, E.; Economopoulos, T.; Pectasides, D.; Gogas, H.; Kosmidis, P.; Bafaloukos, D.; Klouvas, G.; Kyratzis, G.; Aravantinos, G.24-Nov-2015-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPentheroudakis, G.; Kalogeras, K. T.; Wirtz, R. M.; Grimani, I.; Zografos, G.; Gogas, H.; Stropp, U.; Pectasides, D.; Skarlos, D.; Hennig, G.; Samantas, E.; Bafaloukos, D.; Papakostas, P.; Kalofonos, H. P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?Dova, L.; Pentheroudakis, G.; Georgiou, I.; Malamou-Mitsi, V.; Vartholomatos, G.; Fountzilas, G.; Kolaitis, N.; Kitsiou, E.; Pavlidis, N.24-Nov-2015-
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapyFountzilas, G.; Valavanis, C.; Kotoula, V.; Eleftheraki, A. G.; Kalogeras, K. T.; Tzaida, O.; Batistatou, A.; Kronenwett, R.; Wirtz, R. M.; Bobos, M.; Timotheadou, E.; Soupos, N.; Pentheroudakis, G.; Gogas, H.; Vlachodimitropoulos, D.; Polychronidou, G.; Aravantinos, G.; Koutras, A.; Christodoulou, C.; Pectasides, D.; Arapantoni, P.24-Nov-2015-
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group studyFountzilas, G.; Skarlos, D.; Katsohis, C.; Pavlidis, N.; Giannakakis, T.; Bafaloukos, D.; Fahantidis, E.; Klouvas, G.; Beer, M.; Kosmidis, P.24-Nov-2015-
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group studyFountzilas, G.; Skarlos, D.; Pavlidis, N. A.; Makrantonakis, P.; Tsavaris, N.; Kalogera-Fountzila, A.; Giannakakis, T.; Beer, M.; Kosmidis, P.24-Nov-2015-
Immunohistochemical Profiling of Signalling Pathways in Cancer of Unknown Primary (CUP)Pentheroudakis, G.; Petrakis, D.; Goussia, A.; Siozopoulou, V.; Bobos, M.; Fountzilas, G.; Cervantes, A.; Malamou-Mitsi, V.; Ciuleanu, T.; Pavlidis, N.24-Nov-2015-
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma - A Hellenic Cooperative Oncology Group Phase II StudyFountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Karanikiotis, C.; Bai, M.; Misailidou, D.; Samantas, E.; Athanassiou, E.; Papamichael, D.; Tsekeris, P.; Catodritis, N.; Nicolaou, A.; Plataniotis, G.; Makatsoris, T.; Papakostas, P.; Zamboglou, N.; Daniilidis, J.24-Nov-2015-
Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and NeckFountzilas, G.; Bamias, A.; Kalogera-Fountzila, A.; Karayannopoulou, G.; Bobos, M.; Athanassiou, E.; Kalogeras, K. T.; Tolis, C.; Tsekeris, P.; Papakostas, P.; Vamvouka, C.; Zaramboukas, T.; Kosmidis, P.; Zamboglou, N.; Misailidou, D.24-Nov-2015-
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic studyBamias, A.; Syrigos, K.; Fountzilas, G.; Tzamakou, E.; Soulti, K.; Karavasilis, V.; Alamanos, Y.; Christodoulou, C.; Pavlidis, N.24-Nov-2015-
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG)Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancerFountzilas, G.; Skarlos, D.; Giannakakis, T.; Athanasiadis, A.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, C.; Pavlidis, N.; Kosmidis, P.24-Nov-2015-
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulationMinas, V.; Rolaki, A.; Kalantaridou, S. N.; Sidiropoulos, J.; Mitrou, S.; Petsas, G.; Jeschke, U.; Paraskevaidis, E. A.; Fountzilas, G.; Chrousos, G. P.; Pavlidis, N.; Makrigiannakis, A.24-Nov-2015-
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancerKalofonos, H. P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K. N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G.24-Nov-2015-
Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literatureLazaridis, G.; Pentheroudakis, G.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)Papaxoinis, G.; Fountzilas, G.; Rontogianni, D.; Dimopoulos, M. A.; Pavlidis, N.; Tsatalas, C.; Pectasides, D.; Xiros, N.; Economopoulos, T.24-Nov-2015-
Matrix metalloproteinases in carcinoma of unknown primaryKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015-
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) studySkarlos, D. V.; Fountzilas, G.; Pavlidis, N.; Beer, M.; Makrantonakis, P.; Aravantinos, G.; Pantelakos, P.; Tsavaris, N.; Karpasitis, N.; Kosmidis, P.24-Nov-2015-
Showing results 52 to 71 of 168 < previous   next >